Fujifilm’s Toyama unit set to publish promising early clinical results in treating Ebola

EJ Lane

SINGAPORE–Fujifilm's Chemical is readying a study for a scientific journal stating that its Avigan (favipiravir) influenza drug has shown promise in ebolavirus so far in an -phase trial in the West African country of Guinea.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS